Document:

<PAGE>

                                                                    EXHIBIT 10.9

                              EMPLOYMENT AGREEMENT

         This Employment Agreement (this "Agreement"), dated as of September 24,
2003, and effective as of July 1, 2003 (the "Effective Date"), is made and
entered into by and between Helix BioMedix, Inc., a Delaware corporation, (the
"Company"), and R. Stephen Beatty (the "Executive").

         The Company and Executive hereby agree as follows:

1.       EMPLOYMENT

The Company will employ Executive and Executive will accept employment by the
Company as President and Chief Executive Officer. During Executive's employment,
Executive shall serve the Company faithfully and to the best of his ability,
devoting substantially all his working time, attention and energies to the
business of the Company, unless otherwise approved in writing by the Board of
Directors of the Company (the "Board"). Subject to the direction of the Board,
Executive will have such reasonable duties, responsibilities, powers and
authority as are prescribed by the Board or the bylaws of the Company. Executive
shall not engage in any other business activity (except the management of
personal investments and charitable and civic activities that in the aggregate
do not interfere with the performance of Executive's duties) without first
obtaining the written consent of the Board, and such consent shall not
unreasonably be withheld.

2.       TERM OF AGREEMENT

The term of this Agreement ("Term") shall commence on July 1, 2003 and will
continue in effect until June 30, 2006, unless otherwise terminated as set forth
herein.

3.       COMPENSATION

         (a)      BASE SALARY. Company shall pay Executive a base salary at an
annual rate of Two Hundred Eighty Five Thousand Dollars ($285,000) payable in
accordance with Company's regular pay schedule for senior management. The Board
shall review Executive's salary and performance annually, and Executive shall be
eligible for an increase in his base salary based on such review.

         (b)      STOCK OPTIONS. The Company shall issue options to Executive to
acquire shares of the Company's common stock ("Shares"), under the following
terms and conditions:

                  (1)      Pursuant to the Company's 2000 Stock Option Plan,
Executive shall be granted an option to purchase Three Hundred Twenty Four
Thousand (324,000) shares of company common stock at an exercise price of $1.00
per share which is $0.07 above the per share reported closing price on the
Effective Date. These options will vest in six equal installments of Fifty Four
Thousand (54,000) shares on January 1, 2004, July 1, 2004, January 1, 2005, July
1, 2005, January 1, 2006 and July 1, 2006. Any unexercised options issued
pursuant to this Section 3(b)(2) shall expire on June 30, 2013.

                  (2)      Executive may, at his or the Company's option, pay
for all or any portion of the aggregate exercise price by delivering a
combination of any or all of the following:

<PAGE>

                           (i)      By delivering shares of the Company's common
         stock previously held by Executive which have a fair market value at
         the date of exercise equal to the aggregate exercise price to be paid
         by Executive upon such exercise;

                           (ii)     By delivering a properly executed exercise
         notice together with irrevocable instructions to a broker to promptly
         deliver to the Company the amount of sale or loan proceeds to pay the
         exercise price; or

                           (iii)    By delivering a full recourse promissory
         note for all or part of the aggregate exercise price, payable on such
         terms and bearing such interest rate as determined by the Board (but in
         no event less than the minimum interest rate specified under the
         Internal Revenue Code at which no additional interest would be imputed
         and in no event more than the maximum interest rate allowed under
         applicable usury laws), which promissory note may be either secured or
         unsecured in such manner as the Board shall approve (including, without
         limitation, by a security interest in shares of the Company's stock).

                  (4)      The Board will qualify the options for an exemption
from registration under the applicable federal and any applicable state
securities laws.

         (d)      INCENTIVE COMPENSATION. Executive shall be entitled to
participate in a manner consistent with all other senior management
participation in any incentive compensation plan which may be adopted by the
Company.

         (e)      BENEFITS.

                  (1)      Executive shall be entitled to receive three weeks
paid vacation and all benefits (such as medical, dental, sick leave, disability,
and retirement benefits) as are generally available from time to time to
employed senior executives of Company.

                  (2)      Company will maintain a policy of insurance for
directors' and officers' liability with such coverage as may be determined by
the Board. Executive will be included within that policy of insurance with the
premiums paid by Company.

                  (3)      Company shall grant to Executive an annual personal
travel allowance of up to Ten Thousand Dollars ($10,000), for travel related to
Executive's duties under this Agreement.

                  (4)      Company shall allow Executive periodic use of a
corporate apartment in Seattle, Washington, until such time as the Executive has
established a residence in the Seattle metropolitan area.

                  (5)      Company shall reimburse Executive for all reasonable
expenses incurred in connection with Executive's relocation to Seattle,
Washington.

                  (6)      Company shall allow Executive periodic use of a
Company vehicle for matters relating to his duties under this Agreement.

                                       2
<PAGE>

                  (7)      For purposes of this section 3(e):

                           (A)      Benefits shall not include benefits to
employees leased to the Company.

                           (B)      Vacation shall not include time spent by
Executive at events attended by (i) persons who hold or represent the holders of
at least 20% of the Company's outstanding voting stock; or (ii) any person with
whom the Company has an existing Consulting Agreement as long as a material
purpose of such time is Company-related. Company hereby acknowledges that
Executive intends to attend certain national bridge-related events during each
year at which a significant percentage of the Company's current stockholders are
present. Company encourages such participation by Executive are hereby
acknowledges that it will reimburse Executive for the reasonable costs of
attending such events and that the time associated with such events will not be
considered as vacation. Company reserves the right to review this situation on a
year-by-year basis.

         (f)      AWARD WARRANT. As of the Effective Date of this Agreement, the
Company shall issue to Executive a warrant that provides Executive with the
right, for a ten-year period, to purchase up to 60,000 shares of the Company's
common stock at a purchase price of $0.25 per share. Such warrant shall be
exercisable in full on October 31, 2003 as long as Executive is still an
employee of the Company on such date.

4.       TERMINATION

Employment of Executive pursuant to this Agreement may be terminated as follows:

         (a)      BY EXECUTIVE. Executive may terminate his employment at any
time, for any reason.

         (b)      BY THE COMPANY. The Company may terminate the employment of
Executive at any time, for any reason, with or without cause.

         (c)      AUTOMATIC TERMINATION. This Agreement and Executive's
employment shall terminate automatically upon the death or total disability of
Executive. The term "total disability" as used in this Agreement shall mean
Executive's inability to perform the duties set forth in Section 1 for a period
or periods aggregating one-hundred twenty (120) calendar days in any 12-month
period as a result of physical or mental illness, loss of legal capacity or any
other cause beyond Executive's control, unless Executive is granted a leave of
absence by the Board. Executive and the Company acknowledge that Executive's
ability to perform the duties specified in Section 1 is of the essence of this
Agreement.

5.       TERMINATION PAYMENTS

In the event of termination of the employment of Executive, all compensation and
benefits set forth in this Agreement shall terminate, except as specifically
provided in this Section 5. For purposes of this Agreement, the effective date
of termination shall be thirty (30) days after the Executive or the Company
gives written notice of termination.

                                       3
<PAGE>

         (a)      TERMINATION BY THE COMPANY WITH CAUSE. Upon termination by the
Company with Cause (as defined below), the Company shall pay Executive any
unpaid annual base salary, earned but unused vacation, and bonuses due (if any),
for services already performed (subject to normal withholding and other
deductions) to the effective date of termination of employment.

         (b)      TERMINATION BY THE COMPANY WITHOUT CAUSE. Upon termination by
the Company without Cause (as defined below), the Company shall pay Executive
any unpaid annual base salary, any amount due but not paid under any Company
incentive compensation plan, earned but unused vacation and bonuses due (if any)
for services already performed (subject to normal withholding and other
deductions) to the effective date of termination of employment; and monthly
severance payments equivalent to six (6) months base salary. These payments will
be made in accordance with the Company's customary payroll schedule, minus
deductions required by law. In addition, any options to purchase capital stock
of the Company held by Executive on the date of such termination shall
automatically be deemed to be fully vested and exercisable. The Company will
issue and file appropriate tax documents in connection with any severance
payments. Payment of the above-described severance compensation and benefits is
conditioned on Executive executing a full mutual release of all claims related
to his employment with or termination from Company in substantially the form
attached hereto as Exhibit A. Such a release will not include accrued and unpaid
wages and benefits, claims to industrial insurance, vested pension benefits or
indemnification rights. Executive will have the duty to mitigate the costs of
Company by attempting to obtain other employment within a reasonable time after
termination; Executive's compensation from such other employment will be
credited against the amounts due from Company to the extent the combined
compensation from Executive's new position and Company's payments under this
Section 5(b) would otherwise exceed Executive's base salary with Company at the
date of termination.

         (c)      TERMINATION BY EXECUTIVE WITHOUT GOOD REASON. Upon termination
by Executive without Good Reason (as defined below), Executive shall be paid the
compensation as set forth in Section 5(a) and shall not be entitled to any other
benefits or payments.

         (d)      TERMINATION BY EXECUTIVE WITH GOOD REASON. Upon termination by
Executive with Good Reason (as defined below), Executive shall receive the
compensation as set forth in Section 5(b) and shall not be entitled to any other
benefits or payments.

         (e)      TERMINATION AS A RESULT OF DEATH OR TOTAL DISABILITY. In the
event of termination of Executive's employment pursuant to Section 4(c),
Executive or his estate shall be paid the compensation set forth in Section 5(a)
and shall not be entitled to any other benefits or payments.

         (f)      DEFINITION OF "CAUSE." "Cause" as used in this Agreement shall
mean a determination by the Board that one or more of the following has
occurred:

                  willful misconduct, or dishonesty in the performance of
                  Executive's duties that results in a material adverse effect
                  on the Company;

                  conviction of Executive of a felony involving an act of
                  dishonesty, moral turpitude, deceit or fraud; or

                                       4
<PAGE>

                  current use by the Executive of illegal substances.

         (g)      DEFINITION OF "GOOD REASON." "Good reason" shall mean the
occurrence of any of the following events, without the consent of the Executive:

                  a demotion or other material reduction in the nature or status
                  of Executive's responsibilities; or"

                  a material reduction in Executive's annual base salary or any
                  failure by the Company to satisfy its duty to compensate the
                  Executive as required under this Agreement.

6.       INTELLECTUAL PROPERTY

Company shall own all right, title and interest (including patent rights,
copyrights, trade secret rights, mask work rights, sui generis database rights
and all other intellectual rights of any sort throughout the world) relating to
any and all inventions (whether or not patentable), works of authorship, mask
works, designs, know-how, ideas and information made or conceived or reduced to
practice, in whole or in part, by Executive during the term of Executive's
employment with Company to and only to the fullest extent allowed by Washington
Revised Code Annotated Section 49.44.140 (which is attached as Exhibit B)
(collectively "Inventions") and Executive will promptly disclose all Inventions
to Company. Executive will also disclose anything Executive believes is excluded
by Section 49.44.140 so that Company can make an independent assessment.
Executive hereby makes all assignments necessary to accomplish the foregoing.
Executive shall further assist Company, at Company's expense, to further
evidence, record and perfect such assignments, and to perfect, obtain, maintain,
enforce, and defend any rights specified to be so owned or assigned. Executive
hereby irrevocably designates and appoints Company as its agents and
attorneys-in-fact to act for and in Executive's behalf to execute and file any
document and to do all other lawfully permitted acts to further the purposes of
the foregoing with the same legal force and effect as if executed by Executive.
If Executive wishes to clarify that something created by Executive prior to
Executive's employment that relates to Company's actual or proposed business is
not within the scope of this Agreement, Executive has listed it on Exhibit C. If
Executive uses or (except where disclosed pursuant to this Section 6 as a
claimed exclusion to RCW 49.44.140 or in Exhibit C) discloses Executive's own or
any third party's confidential information or intellectual property when acting
within the scope of Executive's employment or otherwise on behalf of Company,
Company will have and Executive hereby grants Company a perpetual, irrevocable,
worldwide royalty-free, non-exclusive, sublicensable right and license to
exploit and exercise all such confidential information and intellectual property
rights. To the extent allowed by law, this section includes all rights of
paternity, integrity, disclosure and withdrawal and any other rights that may be
known as or referred to as "moral rights," "artist's rights," "droit moral," or
the like (collectively "Moral Rights"). To the extent Executive retains any such
Moral Rights under applicable law, Executive hereby ratifies and consents to any
action that may be taken with respect to such Moral Rights by or authorized by
Company and agree not to assert any Moral Rights with respect thereto. Executive
will confirm any such ratifications, consents and agreements from time to time
as requested by Company.

                                       5
<PAGE>

7.       PRIVACY

Executive recognizes and agrees that Executive has no expectation of privacy
with respect to Company's telecommunications, networking or information
processing systems (including, without limitation, stored computer files, email
messages and voice messages) and that Executive's activity and any files or
messages on or using any of those systems may be monitored at any time without
notice.

8.       RESTRICTIVE COVENANTS

Executive acknowledges: (i) that Executive will have access during his
employment with Company to confidential information regarding all Inventions and
all other business, technical and financial information (including, without
limitation, the identity of and information relating to customers or employees)
Executive develops, learns or obtains during the term of Executive's employment
that relates to Company or the business or demonstrably anticipated business of
Company or that are received by or for Company in confidence, and that all such
information constitutes "Proprietary Information"; (ii) that information
regarding Proprietary Information constitutes a valuable asset and trade secret
of Company; and (iii) that it is reasonable for Company to protect itself from
misappropriation of Proprietary Information by Executive upon termination of
employment or otherwise. Accordingly, in consideration of employment hereunder,
and other good and valuable consideration, Executive agrees to the following
nondisclosure, noninterference and noncompetition covenants during the Term and
for a period of twenty-four (24) months after the Term:

         (a)      NONDISCLOSURE. Executive will not copy, remove, or disclose
any Proprietary Information, except as may be required by law or in the course
of performing services for Company, Executive will hold in confidence and not
disclose or, except within the scope of Executive's employment, use any
Proprietary Information at any time, even after Executive's employment with
Company ends for whatever reason. However, Executive shall not be obligated
under this paragraph with respect to information Executive can document by clear
and convincing evidence is or becomes readily publicly available without
restriction through no fault of Executive. Upon termination of Executive's
employment or if sooner requested, Executive will promptly return to Company all
items containing or embodying Proprietary Information (including all copies),
except that Executive may keep Executive's personal copies of (i) Executive's
compensation records, (ii) materials distributed to stockholders generally and
(iii) this Agreement;

         (b)      NONINTERFERENCE. Executive will not employ, solicit, or seek
to employ any person who is an employee of Company or its subsidiaries (i) as of
the date hereof; (ii) during the Term, or (iii) at the time of employment or
solicitation; and

         (c)      NONCOMPETITION AND NONSOLICITATION. Executive will not,
directly or indirectly, as principal, agent, employee, officer, shareholder,
consultant or otherwise, engage in any business that competes directly with
Company, and will not solicit or aid in soliciting, endeavor to obtain as a
customer or client, accept sales, marketing, financial, or consulting business
from, or perform sales, marketing, consulting or related business for any
person, firm, corporation, association or other entity: (i) that is or was a
Company customer for whom Executive performed any services or with whom
Executive had maintained substantial business contacts at

                                       6
<PAGE>

any time during the Term; or (ii) whose business Executive solicited, either
alone or in conjunction with others, on behalf of Company or any of its
subsidiaries during the Term.

         Executive acknowledges and agrees: (i) that a breach of any of the
covenants contained in this Section 8 would cause irreparable injury to Company
for which monetary damages alone would be inadequate to compensate and protect
Company; (ii) that Company may therefore seek and obtain injunctive relief to
enjoin any breach of such restrictive covenants in addition to, and not in
limitation of, any other legal or equitable remedies that are available as a
matter, of law or equity; and (iii) that specific enforcement of this Agreement
by way of an injunction shall not prevent Executive from earning a reasonable
livelihood. Executive further acknowledges and agrees that the nondisclosure,
noninterference, noncompetition and nonsolicitation covenants contained herein
are necessary for the protection of Company's legitimate business interests and
are reasonable in duration, geographic scope, and other content. However, in the
event a court of competent jurisdiction should decline to enforce any term of
the nondisclosure, noninterference, noncompetition or nonsolicitation covenants,
as written herein, such covenant shall be deemed to be modified to require
confidentiality and restrict Executive's interference, competition and
solicitation with Company and its subsidiaries to the maximum duration,
geographic scope, and other content that the court shall find enforceable.

9.       ASSIGNMENT

Except as may be provided under Section 3(b) above, this Agreement is personal
to Executive and shall not be assignable by Executive. If the Company changes it
name or changes to another corporate form, this Agreement will remain in effect
between the Executive and the Company's successor. All the terms and provisions
of this Agreement shall be binding on and shall inure to the benefit of and be
enforceable by the parties and their respective successors and permitted
assigns.

10.      WAIVERS

No delay or failure by any party to this Agreement in exercising, protecting or
enforcing any of its rights, titles, interests or remedies hereunder, and no
course of dealing or performance with respect thereto, shall constitute a
waiver. The express waiver by a party of any right, title, interest or remedy in
a particular instance or circumstance shall not constitute a waiver in any other
instance or circumstance. All rights and remedies shall be cumulative and not
exclusive of any other rights or remedies.

11.      ARBITRATION

Any controversies or claims arising out of or relating to this Agreement shall
be fully and finally settled by arbitration in the city of Seattle, Washington
in accordance with the Employment Arbitration Rules of the American Arbitration
Association then in effect (the "AAA Rules"), conducted by one arbitrator either
mutually agreed upon by the Company and Executive or chosen in accordance with
the AAA Rules, except that the parties shall have any right to discovery as
would be permitted by the Federal Rules of Civil Procedure for a period of 90
days following the commencement of such arbitration, and the arbitrator shall
resolve any dispute that arises in connection with such discovery. Judgment upon
the award rendered by the arbitrator may be entered in any court having
jurisdiction.

                                       7
<PAGE>

12.      AMENDMENTS IN WRITING

No amendment, modification, waiver, termination or discharge of any provision of
this Employment Agreement, nor consent to any departure from any provision of
this Agreement by either party, shall in any event be effective unless the same
shall be in writing, specifically identifying this Agreement and the provision
intended to be amended, modified, waived, terminated or discharged and signed by
the Company and Executive, and each such amendment, modification, waiver,
termination or discharge shall be effective only in the specific instance and
for the specific purpose for which given. No provision of this Agreement shall
be varied, contradicted or explained by any oral agreement, course of dealing or
performance or any other matter not set forth in an agreement in writing and
signed by the Company and Executive.

13.      APPLICABLE LAW

This Agreement shall in all respects, including all matters of construction,
validity and performance, be governed by, and construed and enforced in
accordance with, the laws of the state of Washington, without regard to any
rules governing conflicts of laws.

14.      SEVERABILITY

If any provision of this Agreement shall be held invalid, illegal or
unenforceable in any jurisdiction, for any reason, including, without
limitation, the duration of such provision, its geographical scope or the extent
of the activities prohibited or required by it, then, to the full extent
permitted by law (a) all other provisions shall remain in full force and effect
in such jurisdiction and shall be liberally construed in order to carry out the
intent of the parties as nearly as may be possible, (b) such invalidity,
illegality or unenforceability shall not affect the validity, legality or
enforceability of any other provision, and (c) any court or arbitrator having
jurisdiction shall have the power to reform such provision to the extent
necessary for such provision to be enforceable under applicable law.

15.      HEADINGS

All headings used in this Agreement are for convenience only and shall not in
any way affect the construction of, or be taken into consideration in
interpreting, this Agreement.

16.      COUNTERPARTS

This Agreement, and any amendment or modification entered into pursuant to
Section 12, may be executed in any number of counterparts, each of which
counterparts, when so executed and delivered, shall be deemed to be an original
and all of which counterparts, taken together, shall constitute one and the same
instrument.

17.      ENTIRE AGREEMENT

This Agreement and the Indemnification Agreement between Executive and the
Company (and any addenda, amendments or extensions to those agreements)
constitute the entire agreement between the Company and Executive with respect
to the subject matters of this Agreement and the Indemnification Agreement.

                                       8
<PAGE>

HELIX BIOMEDIX, INC.                    EXECUTIVE:

/s/ Jeff Miller                         /s/ R. Stephen Beatty
-------------------------------------   ----------------------------------------
Jeff Miller                             R. Stephen Beatty
Director

                                       9
<PAGE>

                                    EXHIBIT A

WAIVER AND RELEASE

For and in consideration of the severance payments and benefits set out in the
Employment Agreement attached hereto, Executive, on behalf of himself and his
agents, heirs, successors and assigns, expressly waives any claims against
Company and releases Company (including its officers, directors, stockholders,
managers, agents and representatives) from any and all claims, demands,
liabilities, damages, obligations, actions or causes of action of any kind,
known or unknown, past or present, arising out of, relating to, or in connection
with Executive's employment, termination of employment, or the holding of any
office with Company or any other related entity. The claims released by
Executive include, but are not limited to, claims for defamation, libel,
invasion of privacy, intentional or negligent infliction of emotional distress,
wrongful termination, constructive discharge, breach of contract, breach of the
covenant of good faith and fair dealing, breach of fiduciary duty, fraud, or for
violation of any federal, state or other governmental statute or ordinance,
including, without limitation, Title VII of the Civil Rights Act of 1964, the
federal Age Discrimination in Employment Act, the Americans with Disabilities
Act, the Family and Medical Leave Act, the Employment Retirement Income Security
Program or any other legal limitation on the employment relationship.

This waiver and release shall not waive or release claims (1) where the events
in dispute first arise after execution of this Release; (2) for rights or
benefits due under the Employment Agreement attached hereto; or (3) relating to
Executive's rights to indemnity as a corporate officer of Company.

Executive agrees he has been provided the opportunity to consider whether to
enter into this Release, and has voluntarily chosen to enter into it on this
date. This Release shall be effective when signed. Executive acknowledges that
she is voluntarily executing this Release, that she has carefully read and fully
understands all aspects of this Release and the attached Employment Agreement,
that she has not relied upon any representations or statements not set forth
herein or made by Company's agents or representatives, that she has been advised
to consult with an attorney prior to executing the Release, and that, in fact,
she has consulted with an attorney of his choice as to the subject matter and
effect of this Release.

_____________________________________      _____________________________________
Date                                       Executive

<PAGE>

                                    EXHIBIT B

               WASHINGTON REVISED CODE ANNOTATED SECTION 49.44.140

Washington Revised Code Annotated Section 49.44.140 provides as follows:

         A provision in an employment agreement that provides that an employee
         shall assign or offer to assign any of the employee's rights in an
         invention to the employer does not apply to an invention for which no
         equipment, supplies, facilities, or trade secret information of the
         employer was used and that was developed entirely on the employee's own
         time, unless:

         (a)      the invention relates (i) directly to the business of the
         employer, or (ii) to the employer's actual or demonstrably anticipated
         research or development, or

         (b)      the invention results from any work performed by the employee
         for the employer.

         Any provision that purports to apply to such an invention is to that
         extent against the public policy of this state and is to that extent
         unenforceable.

         An employer shall not require a provision made void and unenforceable
         by subsection (a) of this section as a condition of employment or
         continuing employment.

<PAGE>

                                    EXHIBIT C

None.<PAGE>

                                                                   EXHIBIT 10.10

                           [Helix BioMedix Letterhead]

May 19,  2003

Mr. Parker Sroufe
Executive Vice President, Marketing
Helix BioMedix, Inc.
22122 20th Avenue SE
Bothell, Washington 98021

Dear Parker:

         It is our pleasure to present you with this offer letter for stock
options. The purpose of this letter is to describe the stock options offered to
you by Helix Biomedix Inc. ("Helix") and your non-competition obligations, which
we discussed previously.

         Helix offers you fifty thousand (50,000) qualified stock options at
$1.00/share that vest on May 31, 2003, and an additional fifty thousand (50,000)
qualified stock options at $1.00/share that vest on May 31, 2004. Except for the
vesting date, these stock options shall be subject to the terms and conditions
of the Helix Biomedix, Inc. 2000 Stock Option Plan, initially adopted November
6, 2000 and amended as of August 1, 2002 (a copy of which we have provided to
you).

         You agree that, during the term of your employment with Helix and for
one (1) year after any termination or expiration thereof, for any reason or for
no reason, you shall not, without the prior written consent of Helix, invest,
carry on, engage or become involved, directly or indirectly, either as an
employee, agent, advisor, officer, director, manager, partner, joint venturer,
participant or consultant in any business enterprise (other than Helix or any of
its subsidiaries, affiliates, successors or assigns) in the United States that
derives any material revenues from the Business; provided, however, your
non-competition obligations shall not prevent you from: (i) leasing or renting
real property to a third party in the Business, on customary commercial real
estate lease or rental terms, in which you own a direct or indirect interest;
(ii) marrying a person then engaged in the Business and thereby being deemed,
directly or indirectly, to own, share in the earnings of, or invest in the
stocks, bonds or other securities of any business or entity owned, directly or
indirectly or in whole or in part, by such person that you marry, provided that
you shall not be engaged or take part in, render services to or otherwise serve
as an officer, director or employee of any such business or entity; or (iii)
beneficially owning, directly or indirectly, 5% or less of any class of
securities of an entity that has a class of securities registered under Section
12 of the Securities Exchange Act of 1934, as amended, so long as such
securities ownership does not include any operational, managerial or consulting
relationship with such corporation or entity.

<PAGE>

         As used herein, the "Business" means any individual, business or
company (a) that is a current customer of Helix; (b) that was a customer of
Helix within the three-year period prior to the termination or expiration of
your employment; (c) with which you had material discussions for licensing
Helix's peptides, within the three -year period just prior to the termination or
expiration of your employment; or (d) creates, designs, develops, researches,
promotes, markets, distributes, advertises, sells, offers for sale, makes, uses
or imports, or is attempting to or planning to create, design, develop,
research, promote, market, distribute, advertise, sell, offer for sale, make,
use or import peptides or peptide-based products or services that compete with
Helix.

         We agree that your stock options are in consideration for, among other
things, services rendered and to be rendered by you as an employee of Helix,
that certain Confidentiality And Nondisclosure Agreement, dated June 1, 2002, by
and between you and Helix, and the non-competition clause contained in this
letter

         If you find this letter agreement acceptable, please sign, date and
return it to me. If you have any questions or I can assist you in any way,
please contact me directly.

         Sincerely,

         /s/

         R. Stephen Beatty
         President and CEO

AGREED AND ACCEPTED:

By: /s/ (Parker Sroufe)
    ----------------------------------

Dated: 5/19/03

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00063-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00063-of-00352.parquet"}]]